The Dutch biotech association HollandBIO is calling on the European Commission to explicitly embed biotechnology in European circular policy. In a November 11th press release, the organization explains that biotech can help close material and carbon flows more effectively, provided that regulations and market conditions allow for this. The timing is relevant, as Brussels is working on several dossiers that directly relate to biobased innovation.
Frameworks that allow innovation
According to HollandBIO, more is needed than just ambitions on paper. In practice, companies face fragmented regulations and slow approval procedures. This makes it harder for biobased solutions to get off the ground than conventional alternatives. The association calls for clear frameworks that allow for innovation, with predictable requirements for safety and quality. This should accelerate investments and facilitate scaling up, so that biobased raw materials and biochemicals can gain market share more quickly.
Level playing field in the market
HollandBIO also emphasizes the importance of a level playing field. Biobased materials and processes often compete with fossil fuel options that have cost advantages due to established infrastructure and tax incentives. With consistent European definitions, better coordination between policy areas, and targeted market incentives, demand for biobased applications can increase. This is necessary to make the circular economy truly work in the chemical, materials, and agricultural chains.
Source: HollandBio.nl
